These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 16405604

  • 1. Effect of calcipotriol on epidermal cell populations in alefacept-treated psoriatic lesions.
    van Duijnhoven MW, Körver JE, Vissers WH, van Vlijmen-Willems IM, Pasch MC, van Erp PE, Van de Kerkhof PC.
    J Eur Acad Dermatol Venereol; 2006 Jan; 20(1):27-33. PubMed ID: 16405604
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The effect of alefacept on T-cell subsets and cells expressing NK receptors in lesional psoriatic skin: the effects of monotherapy and combination treatment with calcipotriol.
    Vissers WH, van Duijnhoven M, van Erp PE, de Jong EM, van de Kerkhof PC.
    J Dermatolog Treat; 2008 Jan; 19(6):344-50. PubMed ID: 19016104
    [Abstract] [Full Text] [Related]

  • 4. A double-blind, randomized quantitative comparison of calcitriol ointment and calcipotriol ointment on epidermal cell populations, proliferation and differentiation.
    Körver JE, Vissers WH, van Rens DW, Pasch MC, van Erp PE, Boezeman JB, van De Kerkhof PC.
    Br J Dermatol; 2007 Jan; 156(1):130-7. PubMed ID: 17199579
    [Abstract] [Full Text] [Related]

  • 5. Novel quantitative immunofluorescent technique reveals improvements in epidermal cell populations after mild treatment of psoriasis.
    van Duijnhoven MW, Hagenberg R, Pasch MC, van Erp PE, van de Kerkhof PC.
    Acta Derm Venereol; 2005 Jan; 85(4):311-7. PubMed ID: 16191851
    [Abstract] [Full Text] [Related]

  • 6. Explorative immunohistochemical study to evaluate the addition of a topical corticosteroid in the early phase of alefacept treatment for psoriasis.
    Bovenschen HJ, Gerritsen WJ, van Rens DW, Seyger MM, de Jong EM, van de Kerkhof PC.
    Arch Dermatol Res; 2007 Feb; 298(9):457-63. PubMed ID: 17136563
    [Abstract] [Full Text] [Related]

  • 7. The effect of the combination of calcipotriol and betamethasone dipropionate versus both monotherapies on epidermal proliferation, keratinization and T-cell subsets in chronic plaque psoriasis.
    Vissers WH, Berends M, Muys L, van Erp PE, de Jong EM, van de Kerkhof PC.
    Exp Dermatol; 2004 Feb; 13(2):106-12. PubMed ID: 15009104
    [Abstract] [Full Text] [Related]

  • 8. The effects of calcipotriol and methylprednisolone aseponate on bcl-2, p53 and ki-67 expression in psoriasis.
    Adişen E, Gülekon A, Erdem O, Dursun A, Gürer MA.
    J Eur Acad Dermatol Venereol; 2006 May; 20(5):527-33. PubMed ID: 16684279
    [Abstract] [Full Text] [Related]

  • 9. Epidermal cell DNA content and intermediate filaments keratin 10 and vimentin after treatment of psoriasis with calcipotriol cream once daily, twice daily and in combination with clobetasone 17-butyrate cream or betamethasone 17-valerate cream: a comparative flow cytometric study.
    Glade CP, Van Erp PE, Van De Kerkhof PC.
    Br J Dermatol; 1996 Sep; 135(3):379-84. PubMed ID: 8949429
    [Abstract] [Full Text] [Related]

  • 10. Assessment of epidermal subpopulations and proliferation in healthy skin, symptomless and lesional skin of spreading psoriasis.
    Körver JE, van Duijnhoven MW, Pasch MC, van Erp PE, van de Kerkhof PC.
    Br J Dermatol; 2006 Oct; 155(4):688-94. PubMed ID: 16965416
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Topical treatment of mild to moderate plaque psoriasis with 0.3% tacrolimus gel and 0.5% tacrolimus cream: the effect on SUM score, epidermal proliferation, keratinization, T-cell subsets and HLA-DR expression.
    Vissers WH, van Vlijmen I, van Erp PE, de Jong EM, van de Kerkhof PC.
    Br J Dermatol; 2008 Apr; 158(4):705-12. PubMed ID: 18284400
    [Abstract] [Full Text] [Related]

  • 13. Biologic effects of topical calcipotriol (MC 903) treatment in psoriatic skin.
    Reichrath J, Müller SM, Kerber A, Baum HP, Bahmer FA.
    J Am Acad Dermatol; 1997 Jan; 36(1):19-28. PubMed ID: 8996256
    [Abstract] [Full Text] [Related]

  • 14. Treatment of plaque psoriasis with the two-compound product calcipotriol/betamethasone dipropionate versus both monotherapies: an immunohistochemical study.
    van der Velden HM, Pasch MC, van Erp PE, van Lingen RG, Otero ME, de Boer-van Huizen RT, van de Kerkhof PC.
    J Dermatolog Treat; 2010 Jan; 21(1):13-22. PubMed ID: 20055694
    [Abstract] [Full Text] [Related]

  • 15. Effect of calcipotriol on etanercept partial responder psoriasis vulgaris and psoriatic arthritis patients.
    Campione E, Mazzotta A, Paternò EJ, Diluvio L, Prinz JC, Chimenti S.
    Acta Derm Venereol; 2009 Jan; 89(3):288-91. PubMed ID: 19479128
    [Abstract] [Full Text] [Related]

  • 16. The effect of topical corticosteroids in combination with alefacept on circulating T-cell subsets in psoriasis.
    Langewouters AM, Bovenschen HJ, De jong EM, Van Erp PE, Van De Kerkhof PC.
    J Dermatolog Treat; 2007 Jan; 18(5):279-85. PubMed ID: 17852631
    [Abstract] [Full Text] [Related]

  • 17. Topical calcipotriol for psoriasis--an immunohistologic study.
    Mozzanica N, Cattaneo A, Schmitt E, Diotti R, Finzi AF.
    Acta Derm Venereol Suppl (Stockh); 1994 Jan; 186():171-2. PubMed ID: 7915481
    [Abstract] [Full Text] [Related]

  • 18. Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis.
    Austad J, Bjerke JR, Gjertsen BT, Helland S, Livden JK, Morken T, Mørk NJ.
    J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):19-24. PubMed ID: 9731961
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of calcipotriol ointment applied under hydrocolloid occlusion in psoriasis.
    Castelijns FA, Gerritsen MJ, van Erp PE, van de Kerkhof PC.
    Dermatology; 2000 Jul; 200(1):25-30. PubMed ID: 10681609
    [Abstract] [Full Text] [Related]

  • 20. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.
    de Korte J, van der Valk PG, Sprangers MA, Damstra RJ, Kunkeler AC, Lijnen RL, Oranje AP, de Rie MA, de Waard-van der Spek FB, Hol CW, van de Kerkhof PC.
    Br J Dermatol; 2008 Feb; 158(2):375-81. PubMed ID: 18067483
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.